Nextremity Solutions LLC announced it has obtained ISO 13485 Certification of its Quality Management System and CE Mark Certification of the NEXTRA Hammertoe Correction System. The NEXTRA System is a key component to the company's forefoot reconstruction portfolio and was introduced for limited release at the American Orthopaedic Foot & Ankle Society Congress, July 13-15 in Keystone, Colorado. The global launch of the product will commence in early 2012.
Arthur Alfaro, President & CEO, comments that, "We are very proud to have achieved ISO certification at such an early stage in the company's development and conform to a global quality standard for medical devices. The additional CE Mark Certification of the NEXTRA Hammertoe System allows us to now initiate the global commercial release of our First-in-Class surgical procedure kit and implant for treating a foot deformity which affects 10 to 20% of the population. The company will now mobilize its resources to train orthopaedic surgeons, podiatric surgeons and trauma surgeons in what we believe will be a game changing product. NEXTRA is our first product in a series of highly differentiated surgical solutions for one of the fastest growing sectors in the medical device industry."
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology